Global market valuation was derived through revenue triangulation and healthcare infrastructure deployment analysis. The methodology included:
Identification of 60+ key stakeholders across healthcare ERP vendors (SAP, Oracle, Infor), RFID/barcode hardware manufacturers, cloud-native SCM startups, pharmaceutical serialization solution providers, and GPO technology arms across North America, Europe, Asia-Pacific, and Latin America
Product mapping across software (SaaS, on-premise, hybrid), hardware (RFID tags, scanners, mobile computers), and services (implementation, maintenance, consulting) categories
Segment-specific analysis covering Forecasting & Planning, Inventory Management, Warehouse Management, and Reverse Logistics functions
Delivery mode stratification: Cloud-based (public/private), Web-based, and Legacy On-premise installations
End-user revenue allocation across Healthcare Providers (IDNs, standalone hospitals, ASCs), Healthcare Manufacturers (pharmaceutical, medical devices, biologics), and Distributors (wholesale, specialty pharmacy, 3PL)
Analysis of reported and modeled annual revenues specific to healthcare SCM portfolios, excluding non-healthcare vertical revenues from diversified conglomerates
Coverage of manufacturers and service providers representing 75-80% of global market share in 2024
Extrapolation using bottom-up approach (number of healthcare facilities × SCM adoption rate × average selling price by hospital bed size and region) and top-down validation (vendor revenue reconciliation by component and geography) to derive segment-specific valuations for Build-to-Order, Continuous Replenishment, and Make-to-Stock deployment models